Gene Locus : human-BCHE
Mode of mutation : Site directed mutagenesis
Disease :
Summary : Back door hypothesis No changes in Km BTCh or Ki of inhibitors tested Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423
AAA Change :
Allelic Variant :
Risk Factor :
Inhibitor :
Structure :
Disease by interaction :
Interact Gene Locus :
Xenobiotic sensitivity :
Modification : Back door hypothesis
Torpedo_number : 129
Kinetic Parameter : Butyrylthiocholine_V127D_human-BCHE, Tacrine_V127D_human-BCHE, Succinylcholine~Suxamethonium_V127D_human-BCHE, Dibucaine_V127D_human-BCHE, Solanine_V127D_human-BCHE, BW284C51_V127D_human-BCHE
News : No news
Comment : p.V127D Val127Asp (p.V155D Val155Asp in primary sequence with 28 amino-acids signal peptide) Back door hypothesis\; No changes in Km BTCh or Ki of inhibitors tested
| Title : Overlapping drug interaction sites of human butyrylcholinesterase dissected by site-directed mutagenesis - Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 |
| Author(s) : Loewenstein-Lichtenstein Y , Glick D , Gluzman N , Sternfeld M , Zakut H , Soreq H |
| Ref : Molecular Pharmacology , 50 :1423 , 1996 |
| Abstract : Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 |
| ESTHER : Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 |
| PubMedSearch : Loewenstein-Lichtenstein_1996_Mol.Pharmacol_50_1423 |
| PubMedID: 8967962 |
| Gene_locus related to this paper: human-BCHE |